|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.GB |
First Approval Date30 Jan 2006 |
|
Mechanism30S subunit inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date14 Jan 1960 |
|
MechanismcGMP-PDE inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date19 Apr 1940 |
100 Clinical Results associated with Mercury Pharmaceuticals Ltd.
0 Patents (Medical) associated with Mercury Pharmaceuticals Ltd.
100 Deals associated with Mercury Pharmaceuticals Ltd.
100 Translational Medicine associated with Mercury Pharmaceuticals Ltd.